S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
about
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
S9918 PSC 833, Daunorubicin, a ...... agnosed Acute Myeloid Leukemia
@en
type
label
S9918 PSC 833, Daunorubicin, a ...... agnosed Acute Myeloid Leukemia
@en
prefLabel
S9918 PSC 833, Daunorubicin, a ...... agnosed Acute Myeloid Leukemia
@en
P4844
P6153
P1050
P1476
A Phase II Study of Daunomycin ...... in Patients of Age 56 or Older
@en
P3098
NCT00004217
P580
2000-02-01T00:00:00Z
P582
2001-05-01T00:00:00Z